MNM Bioscience

From tumor genomes to AI-driven drug discovery

[MNM Bioscience @BioscienceMnm]

💡Simple is not easy.
Despite the complexity of our AI architecture going up, we try hard to make it easy to understand
👉Here, we demonstrate that by using molecular data from real patients powered by Multimodal Machine Learning, it is possible to identify tumor vulnerabilities

[MNM Bioscience @BioscienceMnm]

👉 The #DDR Summit conference will be held in two weeks!

💡 We can’t wait to discuss new approaches to #precision #oncology with the top experts in the field #astrazeneca #merk #novartis #bristolmyerssquibb and many others.

🤝 We hope to meet you there!

[MNM Bioscience @BioscienceMnm]

In the article, Krzysztof Bokiej and @MaciejPiernik explain how ARETEai platform works: https://t.co/5bPu2AhL6k

[MNM Bioscience @BioscienceMnm]

👉The ARETEai is a custom-made, AI-driven platform developed by MNM Bioscience’s experts.
It is making communication easier between biologists, bioinformaticians and data scientists, which is pivotal for advancing drug target discovery and personalized medicine.

[MNM Bioscience @BioscienceMnm]

💡 We have just published exciting results in PLOS Genetics of our cooperation with the COVID-19 Host Genetics Initiative – a global scientific collaboration for COVID research.
🤝 Proud to be part of this global initiative: https://t.co/EXFnmDUHDw

[MNM Bioscience @BioscienceMnm]

Precision #AI is a fusion of #MachineLearning and biological #knowledge. Read the whole story by our VP of AI @MaciejPiernik on why and how we are building precision AI. 👇https://t.co/24c06czq3P

[MNM Bioscience @BioscienceMnm]

By using #AI and #genomic #data from real patients, we can pinpoint which patients will benefit from existing therapies, identify new therapeutic uses for drugs that are already available, and find new #drug targets.
👉Find out more about our technology: https://t.co/vDo7LOloaf

[MNM Bioscience @BioscienceMnm]

👉 Great opportunity to tell the story of how our #precisionAI is being integrated into cancer care.

We hope to see many of you!🤝
https://t.co/1lGuD4RrCO

#precisionAI #drugdevelopment

[MNM Bioscience @BioscienceMnm]

In MNM, we support the culture of sharing, which is why our latest software - the #NeKO ☁ component, will be released on an Open-Source Licence 💪
Great work @pa_piatkowski_ and @bokens01
👉 Find out more: https://t.co/wU5hssWy4k

#cloud #software #bigdata #mnmbioscience

[MNM Bioscience @BioscienceMnm]

Finally! 🤩
Our VP of #AI, @MaciejPiernik had the great pleasure of presenting one of our core #algorithms — Random Similarity Forest — to a wide audience at one of the most important events on #ML and #datamining — #ECMLPKDD. 💪👏
#machinelearning #conference #mnmbioscience

[MNM Bioscience @BioscienceMnm]

Incredible data emphasizing the power of #genomic-based and #AI research presented at #ESMO2022 makes us extremely excited about the future of the fight against cancer.
👉Read more: https://t.co/KbCbnpxoGo

[MNM Bioscience @BioscienceMnm]

Tomorrow, the most anticipated #oncology #conference - #ESMO2022 Congress will be held in Paris, France. The MNM team will present the results of our #research related to the development of a novel #biomarker applicable in the #immunotherapy of non-small cell lung #cancer. 👌

[MNM Bioscience @BioscienceMnm]

We are happy to announce that MNM will support a multi-site PROTECTAA TRIAL. Our #AI platform will be used to stratify breast #cancer patients for anthracycline treatment supported by novel cardioprotective #therapy.💪 More details soon! 🤞

[MNM Bioscience @BioscienceMnm]

More than twenty years after having the first sequenced human #genome, the price of such service had fallen from billions of dollars to just $1000. But that’s not enough! 💪
Find out more on our blog: https://t.co/bCziWxvG9t

[MNM Bioscience @BioscienceMnm]

We are more than happy to announce that our #research on “AUTOMATIC FEATURE EXTRACTION FROM WHOLE-GENOME DATA” has been published in the "Bioinformatics" 💪
Learn more: https://t.co/iJr6RYDdI3

[MNM Bioscience @BioscienceMnm]

MNM's platform ARETE - a proprietary #AI #technology designed for #cancer #genomics has been successfully externally validated by one of our Partners 💪

[MNM Bioscience @BioscienceMnm]

Two fantastic papers published recently in #Nature only proved the importance of MNM’s focus on copy-number changes and structural variant signatures in #cancer #genomes 👌
👉 Find out more on our blog: https://t.co/7DIvskHjrp

[MNM Bioscience @BioscienceMnm]

Faster may mean better, especially in #science....
Nanopore sequencing enables rapid, cost-effective, and decentralized #WGS data analysis and has become a useful tool in #genomic surveillance initiatives across the globe.
Find out more from our blog:
https://t.co/hQu4J8EJ8w

[MNM Bioscience @BioscienceMnm]

We are very happy to announce that our abstract and related publication titled “Random similarity forests” has been accepted at this year’s European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases- @ECMLPKDD! 🥳🥳

[Dominik Glodzik @dominikglodzik]

A thoughtful 2021 review on role of somatic mutations in disease (not cancer). Supplementary table lists known examples to date. I bet the list will soon be longer with new tech for sensitive mutation detection

https://t.co/SNd8HcrszE